PERLMUTTER ROGER M sold EIKN
February 6, 2026 · Form 4 insider transaction
PERLMUTTER ROGER M sold 1,268,891 shares of Eikon Therapeutics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,268,891
Price
N/A
Total value
N/A
InsiderPERLMUTTER ROGER M
RoleOfficer, Director
SecuritySeries A-1 Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateFebruary 6, 2026
Filing dateFebruary 10, 2026
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date.; The securities are held indirectly by the Reporting Person through Perlmutter Consulting, Inc. for the benefit of the Reporting Person. The Reporting Person had the sole pecuniary interest in the securities.